Epstein Files Act: House Votes for Transparency
The Daily Brief — Wednesday, November 19, 2025
A concise, nonpartisan roundup of notable developments from roughly the past 24 hours across the U.S., the world, science, technology, and business. Curated with a Munger‑style focus on incentives, second‑order effects, and what actually moves outcomes.
US News
House passes Epstein Files Transparency Act, 427–1
- The House voted overwhelmingly to require the Justice Department to release Epstein‑related records within 30 days, with protections for victim privacy; the bill heads to the Senate amid signs some leaders may seek amendments that could stretch the timeline. (time.com)
Infant botulism investigation: nationwide ByHeart recall remains in effect
- FDA/CDC continue probing a multistate cluster; as of Nov. 14, officials report 23 hospitalized infants with suspected/confirmed botulism and exposure to ByHeart formula. All unexpired ByHeart lots were recalled Nov. 11. Regulators say the brand is ~1% of U.S. formula supply. (fda.gov)
Global News
Russia’s largest overnight strikes in months hit Ukraine’s west; energy curbs return
- Kyiv reports at least 19 dead and 66 injured after large‑scale missile/drone attacks targeting infrastructure, with emergency power cuts and temporary airport precautions in neighboring Poland. (reuters.com)
UK inflation cools into October; markets price higher odds of BoE easing
- Headline CPI slowed, with official releases showing CPI/CPIH disinflation; data arrive days before the Nov. 26 budget and reinforce expectations of rate cuts. (ons.gov.uk)
After Black Sea disruption, Russia’s Novorossiysk oil loadings resume but lag
- Export flows restarted following a Nov. 14 Ukrainian strike that briefly halted ~2% of global supply; sources say jetty damage keeps loadings 2–3 days behind schedule. (reuters.com)
Science
FDA clears first Arrowhead drug for a rare lipid disorder
- Regulators approved Redemplo for familial chylomicronemia syndrome (FCS), using RNA interference against APOC3; pivotal data showed large triglyceride reductions and lower pancreatitis risk, adding to a fast‑moving field of RNA‑based medicines. (reuters.com)
Sentinel‑6B ocean‑height mission: fresh post‑launch updates (context)
- Following its Nov. 16 launch, NASA highlights the satellite’s role as the new reference for global sea‑level measurement, extending a 30‑year record to guide coastal planning and weather models. (nasa.gov)
Technology
Microsoft leans into “agentic” AI at Ignite
- New “Agent 365” offers an enterprise control plane to authorize/quarantine autonomous AI agents across apps; “Teams Mode” brings collaborative agent features into Microsoft 365; Microsoft details governance and context‑layer updates in its Book of News. (reuters.com)
AI infrastructure chessboard keeps shifting
- OpenAI’s $38B, multi‑year AWS deal underscores the race to secure compute and diversify cloud dependencies, with capacity ramping through 2026–27. (reuters.com)
Business & Markets
Oil softens on inventory builds and oversupply narrative, tempered by Russia‑sanctions risk
- Brent and WTI dipped after a U.S. stockpile rise; analysts note pending U.S. sanctions on Rosneft/Lukoil and Ukraine‑related infrastructure risks as offsets. (reuters.com)
Credit‑card fees settlement advances—merchant pushback continues
- Visa and Mastercard’s revised $38B settlement would trim average swipe fees and let merchants refuse premium rewards cards; approval is up to a federal judge, and retail groups remain opposed. Practical implication: some high‑end cards could be declined at checkout. (investing.com)
Retail watch: Target guidance tightens; Walmart on deck
- Target posted a sales miss and narrowed its full‑year EPS range; investors look to Walmart’s Thursday print for a read on U.S. consumer resilience. (investors.com)
Tonight’s catalyst: Nvidia earnings
- The market focus is on whether data‑center growth and guidance can validate multi‑trillion‑dollar AI capex plans amid rising scrutiny of returns. (moneyweek.com)
What a Munger‑style observer might underline
- Process beats personalities: A discharge‑style, bipartisan supermajority forced sunlight on the Epstein records; incentive shifts can overpower partisan incentives. Watch the Senate’s amendment calculus—delay is a tell. (time.com)
- Bottlenecks price the world: A single Black Sea terminal’s downtime moved a multi‑trillion market and still echoes via loading backlogs—logistics fragility remains a first‑order input to energy pricing. (reuters.com)
- Moats need governance: As “autonomous agents” proliferate, control planes like Agent 365 aren’t features—they’re table stakes for audit, compliance, and ROI. The picks‑and‑shovels are policy as much as silicon. (reuters.com)
- Cash flows over narratives: AI capex requires durable customer economics; tonight’s Nvidia print is a referendum on conversion of hype into free cash flow. (moneyweek.com)
- Small percentages, big consequences: A 10‑basis‑point fee tweak sounds tiny, but optionality to decline premium cards could reshape rewards economics and merchant mix—second‑order effects worth modeling. (investing.com)
Time reference: Items reflect developments largely within the past 24 hours through Wednesday, November 19, 2025 (with limited context where directly market‑relevant).